Therefore, the expression levels of HSPA1A, HSPA1B, HSPA4, HSPA5, HSPA8, HSPA13, and HSPA14 are significantly associated with the prognosis of HCC patients and can be used as potential biomarkers to predict prognosis. Here, HSPA5 is linked to hepatocellular carcinoma.